Prostate Cancer VL

Finding Meaning and Resilience in the Face of Advanced Prostate Cancer - Ángel

Details
Ángel's story begins at 67, when he, a lawyer in the midst of a trial, experienced acute urinary retention, leading to a prostate cancer diagnosis with bone metastases. Prepared for the diagnosis but uncertain of the future, Ángel and his wife faced the news with apprehension, fearing it marked the beginning of the end. However, with the support of a young, empathetic doctor and his own resilience...

Symmetry, Visibility, and Control: The Advantages of the BioProtect Balloon in Prostate Cancer Treatment - Edward Soffen

Details
Edward Soffen discusses the evolution of perirectal spacers in radiation oncology in the third part of the series on "spacer wars." Highlighting his experience with Boston Scientific and BioProtect, he delves into the issues faced with SpaceOAR™, particularly in controlling placement and visibility. The FDA approval of Barrigel® offered more control but still lacked visibility. Dr. Soffen then int...

Genomic Comparison Between African American Men & European American Men with Prostate Cancer - Isra Elhussin

Details
Charles Ryan and Isra Elhussin engage in an enlightening conversation about the disparities in cancer genomic profiling between African and European ancestries. Dr. Elhussin's pioneering research investigates how genetic ancestry and specific gene mutations, notably SPOP mutations more prevalent in those of African ancestry, influence prostate cancer subtypes and treatment responses. Her study hig...

Barrigel® - The Future of Rectal Spacing - Neil Mariados

Details
Neil Mariados presents an endorsement of Barrigel® as the future of rectal spacing in cancer treatment. He contrasts Barrigel with SpaceOAR™, highlighting Barrigel's advantages including controllable, sculptable gel consistency, reversible placement, single-step assembly, and exceptional visibility on various imaging technologies like transrectal ultrasound, CT scan, and MRI. Dr. Mariados, having...

Office Based Therapeutics - Focal Therapy - Under a Paradigm of Certainty LUGPA 2022 Presentation- Fernando Bianco

Details
At the 2022 Large Urology Group Practice Association (LUGPA) annual meeting, Fernando Bianco presented on office-based therapeutics - focal therapy: under a paradigm of certainty during optimizing Ambulatory Surgery Centers (ASC) utilization. Biography: Fernando J. Bianco, MD, Investor in-Chief, Urological Research Network, Miami, FL, Professor of Urology, NOVA Southeastern University, Hollywood,...

Battling Prostate Cancer with Optimism and Perseverance - Hugo Mercado

Details
Hugo Mercado recounts his journey with prostate cancer. Initially unaware of his diagnosis, Hugo discovered his condition indirectly, as doctors didn't explicitly inform him. Despite his family's concern, particularly his wife's hidden distress, Hugo remained strong and healthy, never having been seriously ill before. An active lifestyle, including competitive sports and cycling, served as his the...

The Prostate Cancer Foundation VA Health Initiatives, Executing Precision Oncology within the VA - Matthew Rettig & Isla Garraway

Details
Matthew Rettig and Isla Garraway discuss the progress and aspirations of the Veterans Administration (VA) prostate cancer program, established through a Memorandum of Understanding with the Prostate Cancer Foundation. The program has expanded from six to 13 Centers of Excellence, with the VA committing $50 million to this initiative. Dr. Rettig emphasizes the program's focus on precision oncology,...

Exploring the Potential of Lutetium PSMA in High-Risk Localized Prostate Cancer: The LuTectomy Trial - Renu Eapen

Details
Renu Eapen, a recipient of the PCF Young Investigator Award, details her groundbreaking project on early use of Lutetium PSMA for high-risk localized prostate cancer. The two-cohort clinical trial involves administering Lutetium PSMA upfront, followed by radical prostatectomy. An integral part of the study is the translational work, analyzing changes in the tumor microenvironment in response to Lu...

Addressing Prostate Cancer Health Disparities - Leanne Woods-Burnham

Details
Leanne Woods-Burnham discusses her 2020 Young Investigator Award project with the Prostate Cancer Foundation, focusing on prostate cancer disparities, especially among black men. Her research looks at HER2 expression and its connection to West African ancestry. She explains that HER2 is correlated with this ancestry, rather than self-reported race. The project involves RNA sequencing on tumor tiss...

Longitudinal Patient Sampling and Immune Profiling in Oligometastatic Prostate Cancer - Sophia Kamran

Details
Alicia Morgans speaks with Sophia Kamran, who won the Young Investigator Award in 2021. Dr. Kamran shares her research into the potentially beneficial role of radiation in treating oligometastatic prostate cancer, a field where much remains unknown. She is particularly focused on defining the disease more biologically, while also examining the complex interaction of radiation with the immune syste...